Department of Dermatology, Faculty of Health Sciences, University Hospital of North Norway, St Olavsgate 70, 9406, Harstad, Norway.
Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Dessau, Germany.
Br J Dermatol. 2015 Nov;173(5):1142-55. doi: 10.1111/bjd.14024. Epub 2015 Sep 22.
Hidradenitis suppurativa (HS) is a chronic, inflammatory, debilitating skin disease. The aim of the study was to systematically review the literature and critically answer the question: In patients with HS, do cardiovascular risk factors appear at a significantly higher rate compared with controls? The main search was conducted in Medline, Embase and the Cochrane Central Register. Studies eligible for inclusion were of case-control, cross-sectional and cohort design, and included comparison of any cardiovascular risk factor(s) in patients with HS with those of control groups. An I(2) value > 50% was considered to show substantial heterogeneity. In this case, DerSimonian and Laird random-effect models were considered to compute pooled odds ratios (OR). Otherwise, a fixed-effects model was suitable. Nine studies, with 6174 patients with HS and 24 993 controls, were included. Significant association of HS with obesity [OR 3·45, 95% confidence interval (CI) 2·20-5·38, P < 0·001], central obesity (OR 2·97, 95% CI 1·41-6·25, P = 0·004), active smoking (OR 4·34, 95% CI 2·48-7·60, P < 0·001), history of smoking (OR 6·34, 95% CI 2·41-16·68, P < 0·001), hypertriglyceridemia (OR 1·67, 95% CI 1·14-2·47, P = 0·009), low high-density lipoprotein (HDL) (OR 2·48, 95% CI 1·49-4·16, P < 0·001), diabetes (OR 2·85, 95% CI 1·34-6·08, P = 0·007) and metabolic syndrome (OR 2·22, 95% CI 1·62-3·06, P < 0·001) was detected. Associations were significant both in population and hospital patients with HS, with hospital HS groups having uniformly higher ORs than the population HS groups. Causality could not be assessed. Heterogeneity was substantial in all analyses. This systematic review indicated that cardiovascular risk factors appear at a significantly higher rate in patients with HS compared with controls. The need for screening of patients with HS for modifiable cardiovascular risks is emphasized.
化脓性汗腺炎(HS)是一种慢性、炎症性、使人虚弱的皮肤病。本研究的目的是系统地回顾文献,并批判性地回答以下问题:在 HS 患者中,与对照组相比,心血管危险因素的出现率是否显著更高?主要检索在 Medline、Embase 和 Cochrane 中央登记处进行。符合纳入标准的研究为病例对照、横断面和队列设计,并比较了 HS 患者与对照组之间的任何心血管危险因素。如果 I(2)值>50%,则认为存在显著异质性。在这种情况下,考虑使用 DerSimonian 和 Laird 随机效应模型来计算合并的优势比(OR)。否则,适合使用固定效应模型。纳入了 9 项研究,共纳入 6174 例 HS 患者和 24993 例对照组。HS 与肥胖(OR 3.45,95%置信区间[CI]2.20-5.38,P<0.001)、中心性肥胖(OR 2.97,95%CI 1.41-6.25,P=0.004)、主动吸烟(OR 4.34,95%CI 2.48-7.60,P<0.001)、吸烟史(OR 6.34,95%CI 2.41-16.68,P<0.001)、高三酰甘油血症(OR 1.67,95%CI 1.14-2.47,P=0.009)、低高密度脂蛋白(HDL)(OR 2.48,95%CI 1.49-4.16,P<0.001)、糖尿病(OR 2.85,95%CI 1.34-6.08,P=0.007)和代谢综合征(OR 2.22,95%CI 1.62-3.06,P<0.001)显著相关。在人群和医院 HS 患者中均存在相关性,且医院 HS 组的 OR 普遍高于人群 HS 组。因果关系无法评估。所有分析的异质性均较大。本系统评价表明,与对照组相比,HS 患者的心血管危险因素出现率显著更高。强调需要对 HS 患者进行可改变的心血管风险筛查。